Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | AMT-253 |
Synonyms | |
Therapy Description |
Limited information is currently available on AMT-253, a putative chimeric antigen receptor (CAR) T-cell therapy (Apr 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AMT-253 | AMT 253|AMT253 | Limited information is currently available on AMT-253, a putative chimeric antigen receptor (CAR) T-cell therapy (Apr 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05906862 | Phase I | AMT-253 | AMT-253 in Patients With Selected Advanced Solid Tumours | Recruiting | AUS | 0 |